This compound is a pharmaceutical intermediate used in the manufacturing of ranolazine. It features an epoxide ring and an aromatic ether structure, contributing to its reactivity as a synthetic building block.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2210-74-4
4-dimethylamino-3-methyl-2-butanone
pharmaceutical intermediate
3-Azetidinemethanamine dihydrochloride
pharmaceutical intermediate
6-Ethoxy Abacavir
pharmaceutical intermediate
2-Cyanobenzyl bromide
pharmaceutical intermediate
2-[(2-fluorophenoxy)methyl]oxirane
research compound
Phenyl glycidyl ether
reactive diluent for epoxy resins
N-(3-acetyl-4-(oxiran-2-ylmethoxy)phenyl)butanamide
pharmaceutical intermediate
2-{4-[(Oxiran-2-yl)methoxy]phenyl}ethanimidic acid
pharmaceutical raw material
2-[(2-methoxyphenoxy)methyl]oxirane
RJNVSQLNEALZLC-UHFFFAOYSA-N
COC1=CC=CC=C1OCC2CO2